Rachel Winokur is currently the Chief Business Officer of Bright Health, an insurance company offering exclusive network health plans in partnership with leading health systems. Previously she was a senior executive at Aetna, where she helped found and lead Healthagen, Aetna’s payer-neutral population health management business. Rachel joined Aetna from the Carlyle Group, where she invested in healthcare companies for Carlyle’s US Growth Equity Fund. Prior to that role, she was a corporate officer of Datascope, a publicly-traded medical devices company, and spent several years in operations and business development with Bertelsmann, a global media company. Rachel started her career at Goldman Sachs.
Rachel currently sits on the boards of HealthVerity and HealthReveal. She is also an Advisor to Greycroft Partners and AiCure.
Rachel received an MBA from Stanford University’s Graduate School of Business and a BSE with honors in Biomedical Engineering and Electrical Engineering from Duke University.